Annual EPS
-$114.00
+$949.00+89.28%
December 31, 2023
Summary
- As of February 8, 2025, AVTX annual earnings per share is -$114.00, with the most recent change of +$949.00 (+89.28%) on December 31, 2023.
- During the last 3 years, AVTX annual EPS has risen by +$2362.80 (+95.40%).
- AVTX annual EPS is now -109.42% below its all-time high of $1209.60, reached on December 31, 2017.
Performance
AVTX EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$2.83
+$3373.97+99.92%
September 30, 2024
Summary
- As of February 8, 2025, AVTX quarterly earnings per share is -$2.83, with the most recent change of +$3373.97 (+99.92%) on September 30, 2024.
- Over the past year, AVTX quarterly EPS has increased by +$3373.97 (+99.92%).
- AVTX quarterly EPS is now -100.05% below its all-time high of $6229.70, reached on December 31, 2014.
Performance
AVTX Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$3530.82
+$24.00+0.68%
September 30, 2024
Summary
- As of February 8, 2025, AVTX TTM earnings per share is -$3530.82, with the most recent change of +$24.00 (+0.68%) on September 30, 2024.
- Over the past year, AVTX TTM EPS has increased by +$24.00 (+0.68%).
- AVTX TTM EPS is now -262.58% below its all-time high of $2171.74, reached on September 30, 2015.
Performance
AVTX TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
AVTX EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +89.3% | +99.9% | +0.7% |
| 3 y3 years | +95.4% | +98.9% | -232.2% |
| 5 y5 years | +96.7% | +98.6% | -232.2% |
AVTX EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +95.2% | -103.5% | +99.9% | -1007.7% | +0.7% |
| 5 y | 5-year | at high | +95.4% | -103.3% | +99.9% | -1007.7% | +0.7% |
| alltime | all time | -109.4% | +98.6% | -100.0% | +99.9% | -262.6% | +58.1% |
Avalo Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.83(-99.9%) | -$3530.82(-0.7%) |
| Jun 2024 | - | -$3376.80(+2294.9%) | -$3554.82(+1015.2%) |
| Mar 2024 | - | -$141.00(+1284.0%) | -$318.75(-16.5%) |
| Dec 2023 | -$114.00(-89.3%) | -$10.19(-62.0%) | -$381.75(-38.5%) |
| Sep 2023 | - | -$26.83(-80.9%) | -$620.96(+21.2%) |
| Jun 2023 | - | -$140.73(-31.0%) | -$512.53(-27.1%) |
| Mar 2023 | - | -$204.00(-18.2%) | -$703.00(-33.9%) |
| Dec 2022 | -$1063.00(-55.5%) | -$249.40(-405.6%) | -$1063.00(-16.7%) |
| Sep 2022 | - | $81.60(-124.6%) | -$1276.80(-31.3%) |
| Jun 2022 | - | -$331.20(-41.3%) | -$1857.60(-8.6%) |
| Mar 2022 | - | -$564.00(+21.8%) | -$2032.80(-15.0%) |
| Dec 2021 | -$2388.00(-3.6%) | -$463.20(-7.2%) | -$2390.40(-2.3%) |
| Sep 2021 | - | -$499.20(-1.4%) | -$2445.60(+0.4%) |
| Jun 2021 | - | -$506.40(-45.1%) | -$2436.00(-1.6%) |
| Mar 2021 | - | -$921.60(+77.8%) | -$2476.80(-2.3%) |
| Dec 2020 | -$2476.80(+207.1%) | -$518.40(+5.9%) | -$2534.40(+31.3%) |
| Sep 2020 | - | -$489.60(-10.5%) | -$1929.60(+17.5%) |
| Jun 2020 | - | -$547.20(-44.1%) | -$1641.60(+16.3%) |
| Mar 2020 | - | -$979.20(-1233.3%) | -$1411.20(+75.0%) |
| Dec 2019 | -$806.40 | $86.40(-142.9%) | -$806.40(-39.1%) |
| Sep 2019 | - | -$201.60(-36.4%) | -$1324.80(-58.2%) |
| Jun 2019 | - | -$316.80(-15.4%) | -$3168.00(-6.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$374.40(-13.3%) | -$3398.40(+0.9%) |
| Dec 2018 | -$3456.00(-385.7%) | -$432.00(-78.9%) | -$3369.60(-6.4%) |
| Sep 2018 | - | -$2044.80(+273.7%) | -$3600.00(+6150.0%) |
| Jun 2018 | - | -$547.20(+58.3%) | -$57.60(-166.7%) |
| Mar 2018 | - | -$345.60(-47.8%) | $86.40(-175.0%) |
| Dec 2017 | $1209.60(-122.5%) | -$662.40(-144.2%) | -$115.20(-500.0%) |
| Sep 2017 | - | $1497.60(-471.4%) | $28.80(-100.8%) |
| Jun 2017 | - | -$403.20(-26.3%) | -$3484.80(-18.2%) |
| Mar 2017 | - | -$547.20(+5.6%) | -$4262.40(-21.3%) |
| Dec 2016 | -$5385.60(+54.2%) | -$518.40(-74.3%) | -$5414.40(-15.7%) |
| Sep 2016 | - | -$2016.00(+70.7%) | -$6422.40(+38.5%) |
| Jun 2016 | - | -$1180.80(-30.5%) | -$4637.07(-12.0%) |
| Mar 2016 | - | -$1699.20(+11.3%) | -$5268.80(-5.7%) |
| Dec 2015 | -$3493.21(+59.4%) | -$1526.40(+561.7%) | -$5584.36(-357.1%) |
| Sep 2015 | - | -$230.67(-87.3%) | $2171.74(-276.3%) |
| Jun 2015 | - | -$1812.54(-10.0%) | -$1231.63(-36.8%) |
| Mar 2015 | - | -$2014.76(-132.3%) | -$1948.14(-11.1%) |
| Dec 2014 | -$2191.13(-73.2%) | $6229.70(-271.4%) | -$2191.13(-74.0%) |
| Sep 2014 | - | -$3634.04(+43.7%) | -$8420.84(+75.9%) |
| Jun 2014 | - | -$2529.04(+12.0%) | -$4786.80(+112.0%) |
| Mar 2014 | - | -$2257.76 | -$2257.76 |
| Dec 2013 | -$8168.62 | - | - |
FAQ
- What is Avalo Therapeutics annual earnings per share?
- What is the all time high annual EPS for Avalo Therapeutics?
- What is Avalo Therapeutics annual EPS year-on-year change?
- What is Avalo Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Avalo Therapeutics?
- What is Avalo Therapeutics quarterly EPS year-on-year change?
- What is Avalo Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Avalo Therapeutics?
- What is Avalo Therapeutics TTM EPS year-on-year change?
What is Avalo Therapeutics annual earnings per share?
The current annual EPS of AVTX is -$114.00
What is the all time high annual EPS for Avalo Therapeutics?
Avalo Therapeutics all-time high annual earnings per share is $1209.60
What is Avalo Therapeutics annual EPS year-on-year change?
Over the past year, AVTX annual earnings per share has changed by +$949.00 (+89.28%)
What is Avalo Therapeutics quarterly earnings per share?
The current quarterly EPS of AVTX is -$2.83
What is the all time high quarterly EPS for Avalo Therapeutics?
Avalo Therapeutics all-time high quarterly earnings per share is $6229.70
What is Avalo Therapeutics quarterly EPS year-on-year change?
Over the past year, AVTX quarterly earnings per share has changed by +$3373.97 (+99.92%)
What is Avalo Therapeutics TTM earnings per share?
The current TTM EPS of AVTX is -$3530.82
What is the all time high TTM EPS for Avalo Therapeutics?
Avalo Therapeutics all-time high TTM earnings per share is $2171.74
What is Avalo Therapeutics TTM EPS year-on-year change?
Over the past year, AVTX TTM earnings per share has changed by +$24.00 (+0.68%)